On 4 December 2025, leaders in oncology will gather in Copenhagen for the EU Cancer Mission conference “Advancing cancer care: personalised treatment and innovation for all Europeans.” The event will explore the future of cancer diagnostics and therapy, with a strong focus on translating cutting-edge science into clinical practice across Europe.
We are proud to announce that Robert Aleksandrowicz, CEO of Cellis, has been invited as a speaker in Panel 2: Cancer Immunology and Biomarkers of Immunotherapy (11:35–12:35). This high-level session will highlight how immune system insights and validated biomarkers are transforming treatment decisions and patient outcomes.
Joined by fellow experts from Masaryk University (Czechia) and Aarhus University (Denmark), our CEO will present Cellis’ perspective on macrophage-based immunotherapies and their role in precision oncology.
The conference, hosted at Scandic Hotel Copenhagen, is part of the EU’s broader mission to ensure equitable access to innovative cancer care for all Europeans – and Cellis is proud to be part of that effort.
